Open an account

Cyduct Diagnostics

CYDX · OTC

$0.50−$0.10 (−16.67%)TodayMarket closed ·
No price history for this range.

About CYDX

CYduct Diagnostics, Inc. engages in the development and marketing of technology, applications, medical devices, and procedural techniques for screening, diagnosis, treatment, and management of disease and medical conditions. The company is headquartered in Westport, Connecticut. The company went IPO on 2001-06-21. The firm focuses on the women's healthcare market, primarily breast healthcare and wellness. The company is focused on breast health and wellness through testing methods. The company focuses to provide a technology platform that includes evidence-based personalized breast health risk assessment testing. The firm serves medical schools, hospitals and physicians to develop medical devices and procedural techniques for the screening, diagnosis, treatment and management of disease and medical conditions.

Employees
0
Headquarters
Westport, Connecticut
Listed
Jun 21, 2001
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
cyductdx.com

CYDX key statistics

Market cap
2.57M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
3.69K
Volume
5
Open price
$0.50
High today
$0.50
Low today
$0.50
52 Week high
$2.90
52 Week low
$0.20

Cyduct Diagnostics (CYDX) at a glance

As of Oct 19, 2026, Cyduct Diagnostics (CYDX) shares are priced at $0.50, giving the company a market cap of 2.57M and a price-to-earnings ratio of 0.00.

Volume so far is 5 shares, below the average of 3.69K shares a day.

Over the past year Cyduct Diagnostics has ranged from $0.20 to $2.90, and now sits 11% of the way up that range.

Similar companies

Companies in the same industry as Cyduct Diagnostics

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.